Retatrutide (LY3437943) is a triple agonist of the glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor (GLP-1R), and inhibits GCGR, GIPR, and GLP-1R.Retatrutide can be used to study obesity.
Experience a new level of weight loss that is both sustainable and impactful, allowing you to achieve and maintain your health goals.
Take control of your diabetes with Retatrutide's proven ability to improve blood sugar levels, reducing the need for additional medications and enhancing your overall quality of life.
Embrace the change with Retatrutide and start your journey towards a healthier, more vibrant life today. Discover the difference and transform your health with Retatrutide.
|
Aliase |
GCGR/GIPR/GLP-1R Agonist |
| CAS | 2381089-83-2 |
| MOLECULAR FORMULA | C223H343F3N46O70 |
| MOLECULAR WEIGHT | 4731.33 g/mol |
Our Service Advantages
Packaging and Delivery
The company fully supports customized packing and shipping preferences to meet specific needs, ensuring top priority for customer requirements.
Supply Ability
The MOQ varies by product due to their unique specifications. We encourage you to reach out for detailed information tailored to the specific product of interest.
Lead Time
Delivery schedules adapt to seasonal demands, with a 15 working day delivery time during peak seasons and 7 to 13 working days in off-peak seasons, showcasing efficient and timely delivery.
Retatrutide Research
It’s important to note that retatrutide is still an experimental drug that’s being studied. Meaning, you can’t be prescribed it at this time. However, it definitely shows promise.
Retatrutide is a glucagon-like peptide-1 (GLP-1) agonist, like Wegovy and Ozempic. But, while it works similarly to those drugs, it also acts on two additional hormones: glucose-dependent insulinotropic polypeptide (GIP), which helps manage blood sugar, and glucagon, which can help suppress appetite and burn more energy.
Retatrutide side effects
The study cited some side effects of taking retatrutide, and they tended to be more intense at higher doses. Those included:
Retatrutide vs. Ozempic, Wegovy, and other weight loss drugs
Again, research into retatrutide is ongoing. But data so far show that retatrutide may help people lose even more weight than other popular choices.
Previous research on people who took semaglutide (Ozempic, Wegovy) showed that participants lost about 15% of their body weight after six months on the medication. Mounjaro, which is also made by Eli Lilly, has helped study participants lose up to 23% of their body weight.
FAQ
1.Manufacturer or trading company? Where is the company located?
We pride ourselves on being an integrated industry and trade company, nestled in the heart of Zhengzhou, Henan Province.
2.Where are the main markets?
Our global footprint extends across Europe, America, Southeast Asia, the Middle East, and Africa. We are committed to delivering high-quality products and services to every corner of the world, ensuring our presence is felt internationally.
3.Can you provide a product catalog?
Yes, we can! Please contact our sales manager directly. We will promptly send you our detailed product catalog and pricing information to suit your needs.
4.About the terms and conditions of payment.
We offer a variety of payment options to accommodate your convenience, including T/T (Telegraphic Transfer), Western Union, MoneyGram, and cryptocurrency options, ensuring a seamless transaction process.
About US
Nestled in the heart of Henan Province, Zhengzhou Plastic Body Peptide Trading Co., Ltd embarked on its journey to redefine the chemical and pharmaceutical landscape. Founded on the principles of innovation, integrity, and excellence, we've dedicated ourselves to producing top-tier local anesthetics, pharmaceutical intermediates, steroids, and other crucial raw materials.
Driven by a passion for progress and a commitment to quality, our team has bridged continents, connecting with partners in North America, Eastern Europe, Southeast Asia, and beyond. Each product and solution we develop carries the mark of our rigorous research and customer-centric approach, aiming not just to meet but exceed global standards.
References
